106 related articles for article (PubMed ID: 12523284)
1. New treatment approved for chronic hepatitis B.
FDA Consum; 2002; 36(6):4-5. PubMed ID: 12523284
[No Abstract] [Full Text] [Related]
2. FDA notifications. New treatment approved for chronic hepatitis B.
AIDS Alert; 2002 Nov; 17(11):146-7. PubMed ID: 12412570
[No Abstract] [Full Text] [Related]
3. [Drug approval studies of Viread. As effective in HBeAg positive as also in HBeAg negative patients].
MMW Fortschr Med; 2008 May; 150(21):43. PubMed ID: 18578068
[No Abstract] [Full Text] [Related]
4. [New option for successful therapy of chronic hepatitis B].
Ortleb J
Dtsch Med Wochenschr; 2003 Jul; 128(28-29):1565. PubMed ID: 12899163
[No Abstract] [Full Text] [Related]
5. [The first nucleotide analog permitted. New hepatitis B therapy helps the problem patients, too].
MMW Fortschr Med; 2003 Jun; 145(24):52. PubMed ID: 12866303
[No Abstract] [Full Text] [Related]
6. Tenofovir for the treatment of hepatitis B virus.
Jenh AM; Thio CL; Pham PA
Pharmacotherapy; 2009 Oct; 29(10):1212-27. PubMed ID: 19792994
[TBL] [Abstract][Full Text] [Related]
7. [New antiviral agent. Hepatitis B therapy with slight resistance risk].
MMW Fortschr Med; 2003 Dec; 145(51-52):40. PubMed ID: 14974332
[No Abstract] [Full Text] [Related]
8. From the Food and Drug Administration.
McClellan MB
JAMA; 2002 Nov; 288(17):2112. PubMed ID: 12413360
[No Abstract] [Full Text] [Related]
9. Adefovir dipivoxil in the treatment of chronic hepatitis B.
Rivkin AM
Ann Pharmacother; 2004 Apr; 38(4):625-33. PubMed ID: 14990784
[TBL] [Abstract][Full Text] [Related]
10. Chronic hepatitis B--new goals, new treatment.
Lai CL; Yuen MF
N Engl J Med; 2008 Dec; 359(23):2488-91. PubMed ID: 19052131
[No Abstract] [Full Text] [Related]
11. [Adefovir].
Taéron C
Rev Infirm; 2003 Nov; (95):37-8. PubMed ID: 14705256
[No Abstract] [Full Text] [Related]
12. Update on the management of chronic hepatitis B.
Davis GL
Rev Gastroenterol Disord; 2002; 2(3):106-15. PubMed ID: 12227214
[TBL] [Abstract][Full Text] [Related]
13. Adefovir (Hepsera) for chronic hepatitis B infection.
Daftary MN
Am Fam Physician; 2003 Dec; 68(12):2429-30. PubMed ID: 14705763
[No Abstract] [Full Text] [Related]
14. Suppressing hepatitis B without resistance--so far, so good.
Mailliard ME; Gollan JL
N Engl J Med; 2003 Feb; 348(9):848-50. PubMed ID: 12606741
[No Abstract] [Full Text] [Related]
15. FDA recommends hepatitis B drug.
AIDS Patient Care STDS; 2002 Oct; 16(10):511. PubMed ID: 12437861
[No Abstract] [Full Text] [Related]
16. Resistance to adefovir: a new challenge in the treatment of chronic hepatitis B.
Marcellin P; Asselah T
J Hepatol; 2005 Dec; 43(6):920-3. PubMed ID: 16246449
[No Abstract] [Full Text] [Related]
17. Low-dose adefovir for the treatment of chronic hepatitis B in HIV-infected people.
Brust DG
GMHC Treat Issues; 2001; 15(11-12):8-11. PubMed ID: 11819970
[No Abstract] [Full Text] [Related]
18. What is the optimum dose of adefovir in the treatment of chronic hepatitis B infection?
Simsek H; Shorbagi A; Balaban Y; Tatar G
J Hepatol; 2008 Sep; 49(3):464-5. PubMed ID: 18644652
[No Abstract] [Full Text] [Related]
19. [Adefovir dipivoxil--a further step in the control of chronic viral hepatitis B. There is still a long way to go].
Husa P
Vnitr Lek; 2004 Mar; 50(3):177-80. PubMed ID: 15125364
[No Abstract] [Full Text] [Related]
20. Adefovir dipivoxil for hepatitis B e antigen-positive chronic hepatitis B.
Mukherjee S
N Engl J Med; 2003 Jun; 348(24):2468; author reply 2468. PubMed ID: 12802037
[No Abstract] [Full Text] [Related]
[Next] [New Search]
